ORLANDO, Fla. — Health officials lifted an 11-day pause on Johnson & Johnson COVID-19 vaccinations Friday, as recommended by a Centers for Disease Control advisory panel.
The panel spent hours discussing the rare but serious blood clots associated with the vaccine.
READ: COVID-19 variant cases continuing to rise in Orange County
As of April 21, there were 15 cases of blood clots reported in people who had received the shot out of nearly 8 million doses that were administered.
After pouring over the data for six hours, the decision was made to recommend a restart.
“The benefits clearly outweigh the risks from a population perspective, and an individual perspective,” one advisor said. “While we don’t have all the information, I think we do have enough to move forward.”
Of the 15 reported cases of blood clots, all were in women between the ages of 18 and 59. Three of them died, and seven remain hospitalized.
READ: Only 1 local county reported new coronavirus-related deaths since Wednesday
The panel considered issuing a warning to women under 50 not to take the vaccine. However, some members expressed concern that doing so could deter those women from getting any vaccine at all.
Ultimately the panel voted to have the Food and Drug Administration update the vaccine’s label to make women aware of the risk.
The CDC signed off on the recommendations just two hours later and the FDA is updating its emergency use authorization.
“With these actions, the administration of Johnson & Johnson COVID-19 vaccines can resume immediately,” CDC Director Dr. Rochelle Walensky said.
READ: Orange County officials aim to fight decreased interest in COVID-19 vaccines
The Florida Division of Emergency Management says it will eventually resume Johnson & Johnson COVID vaccinations at the FEMA site at Valencia College, but they haven’t set an exact date.
Officials say they’ll review the CDC and FDA guidance then release more details over the weekend.